|Published (Last):||4 August 2015|
|PDF File Size:||16.89 Mb|
|ePub File Size:||19.15 Mb|
|Price:||Free* [*Free Regsitration Required]|
Clinical applications of radioiodine I in the thyroid diseases. Mayabeque, Cuba. La Habana, Cuba. Radioiodine is a radioactive isotope that is successfully used for the diagnosis and the treatment of benign and malignant thyroid diseases.
Its quality of selectively integrating to the thyroid metabolism and emitting a signal allows it to describe the gland functioning through capture studies, and to delimit the morphology and location of the tissues that capture iodine by means of gammagraphy. It is also a simple, safe and cost-effective radiotherapy used as first-line therapeutics in the control of hyperthyroidism. The dose and right time of application should be individualized according to the etiology and the clinic of each patient.
Radioiodine offers an efficient alternative to reduce the size of non-toxic goiter in addition to supporting the surgical treatment of the differentiated thyroid carcinoma and destroying with ablative doses the tissular remains and the metastatic lesions that can be detected during the gammagraphic follow-up.
Radioiodine depends on the fulfillment of safety regulations against radioactivity. Key words: thyroid disease, radioiodine , hyperthyroidism, goiter, thyroid cancer. El embarazo y la lactancia son contraindicaciones absolutas para administrar I Respecto a otras consideraciones, el tratamiento concomitante de I con amiodarona reduce la entrada del I al tiroides, por lo que disminuye su eficacia, y se deben tomar precauciones adicionales para el uso de I en pacientes con incontinencia urinaria.
Servicios Personalizados Revista. Citado por SciELO. Similares en SciELO. ABSTRACT Radioiodine is a radioactive isotope that is successfully used for the diagnosis and the treatment of benign and malignant thyroid diseases. Rev Cubana Endocrinol [serie en Internet]. Radioiodine treatment of Graves' disease. An assessment of its potential risks. Ann Intern Med. Franklyn JA, Boelaert K. Radiation safety in the treatment of patients with thyroid diseases by radioiodine I: practice recommendations of the American Thyroid Association.
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Navarro DA. Uso del yodo radiactivo: lo nuevo y lo viejo. A randomized controlled trial to evaluate the effectiveness of 2 regimens of fixed iodine I doses for Graves' disease treatment.
Clin Nucl Med. Bartalena L. The dilemma of how to manage Graves' disease in patients with associated orbitopathy. J Clin Endocrinol Metab. Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitre. Eur J Endocrinol. Haugen BR. Endocr Pract. N Engl J Med. Zona de Desarrollo. Santa Cruz del Norte.
These manuscripts contain updated topics with a major clinical or conceptual relevance in modern medicine. The journal adheres to the standards of academic research publications in all aspects including peer-review and ethical principles. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. CiteScore measures average citations received per document published. Read more.